Grantham, Mayo, Van Otterloo & Co (GMO)’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,289,231
| Closed | -$890K | – | 984 |
|
|
2020
Q4 | $890K | Buy |
1,289,231
+160,631
| +14% | +$111K | 0.01% | 582 |
|
|
2020
Q3 | $2.54M | Buy |
1,128,600
+297,625
| +36% | +$670K | 0.02% | 367 |
|
|
2020
Q2 | $2.98M | Sell |
830,975
-380,475
| -31% | -$1.36M | 0.02% | 337 |
|
|
2020
Q1 | $4.6M | Buy |
1,211,450
+460,375
| +61% | +$1.75M | 0.04% | 251 |
|
|
2019
Q4 | $2.26M | Buy |
+751,075
| New | +$2.26M | 0.02% | 371 |
|